Skip to main content
. 2023 Aug 10;13:13042. doi: 10.1038/s41598-023-40107-7

Table 1.

Clinical characterizations of included LBSL patients.

LBSL patient Mutation 1 Mutation 2 Sex Onset age (year) Age at follow-up (year) GMFCS* MACS& SARA score# MRI loes scoreω
MIS 1A c.753G > T (p.M251I) c.228-20delTTinsC (p.R76Sfs*5) F 1.5 10 I I 10.5 10
1B c.473A > T (p.E158V) c.829G > A (p.E277K) M 0.75 1.5 II II N/A 7
1C c.265C > T (p.L89F) c.492 + 2 T > C (p.M134_K165 del) F 5 10 I I 14.5 22
1D c.228-20delTTinsC (p.R76Sfs*5) ? M 3 7 I I 13.5 13
SPLICE 2A c.228-20delTTinsC (p.R76Sfs*5) c.492 + 2 T > C (p.M134_K165 del) M 0.83 13 II II UNK UNK
2B c.228-17C > G c.492 + 2 T > C (p.M134_K165 del) M 0 9 I I 6.5 3
2C c.228-17C > G c.492 + 2 T > C (p.M134_K165 del) M 5 5 I I 4.5 7.5

UNK Unknown because patient is international/not enrolled in ongoing natural history study, N/A Not applicable due to age too young to participate in the test.

*Gross Motor Classification Scale (I–V most severe).

&Manual Ability Classification Scale (I–V most severe).

#Standardized Assessment and Rating of Ataxia Scale (0–40 most severe).

ΩModified Loes Score (0–40 most severe).